CADLCandel Therapeutics Inc. Common Stock
13.13USD-2.74%Mkt Cap: 1.00B $P/E: —3d ago
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients. It develops CAN-2409, which is in Phase 2a clinical trials for the treatment of prostate cancer; and Ph…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap1.00B $
Enterprise Value792.96M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-38.18M $
Revenue/Share—
Last Price13.13 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees55
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-19.76
PEG—
EV/EBITDA-11.12
EV/Revenue—
P/S—
P/B7.45
EPS (TTM)-1.34
EPS (Forward)-0.63
52W Range
4.35093% of range13.82
52W High13.82 USD
52W Low4.350 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-73.54%
ROA-30.50%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-38.31M $
CapEx (TTM)587.00K $
FCF Margin—
FCF Yield-3.56%
Net Debt-152.05M $
Net Debt/EBITDA2.13
Balance Sheet
Debt/Equity0.94
Current Ratio16.09
Quick Ratio15.89
Book Value/Sh1.657 USD
Cash/Share2.634 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)21.00 USD
Upside (mean)+59.9%
Target Range12.00 USD – 29.00 USD
$12.00+59.9% to mean$29.00
# Analysts8
Ownership
Shares Out.76.52M
Float60.06M
Insiders14.85%
Institutions66.97%
Short Interest
Short Ratio9.1d
Short % Float22.49%
Short % Out.17.27%
Shares Short12.66M
Short (prev mo.)16.14M
Technical
SMA 509.976 (+31.6%)
SMA 2006.940 (+89.2%)
Beta-0.50
S&P 52W Chg18.16%
Avg Vol (30d)1.28M
Avg Vol (10d)1.48M
Technical Indicators
RSI (14)75.2
MACD0.8021
MACD Signal0.5223
MACD Hist.+0.2798
BB Upper13.03 USD
BB Middle10.73 USD
BB Lower8.435 USD
BB Width42.84%
ATR (14)0.7461 USD
Vol Ratio (20d)1.07x